Valuation: Orion Oyj

Capitalization 9.36B 10.94B 8.71B 8.11B 14.97B 938B 16.62B 105B 39.84B 439B 41.02B 40.17B 1,612B P/E ratio 2025 *
25.6x
P/E ratio 2026 * 17.6x
Enterprise value 9.4B 10.99B 8.75B 8.15B 15.04B 943B 16.7B 105B 40.03B 441B 41.21B 40.36B 1,620B EV / Sales 2025 *
5.6x
EV / Sales 2026 * 4.66x
Free-Float
89.32%
Yield 2025 *
2.58%
Yield 2026 * 2.78%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.37%
1 week+7.25%
Current month+4.31%
1 month+5.71%
3 months+37.32%
6 months+47.57%
Current year+55.68%
More quotes
1 week 62.7
Extreme 62.7
67.7
1 month 61.7
Extreme 61.7
67.7
Current year 42.8
Extreme 42.8
67.7
1 year 39.39
Extreme 39.39
67.7
3 years 31.86
Extreme 31.86
67.7
5 years 31.86
Extreme 31.86
67.7
10 years 22.57
Extreme 22.57
67.7
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 2022-10-31
Director of Finance/CFO 49 2024-04-30
Chief Operating Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 59 2016-03-21
Director/Board Member 62 2017-03-21
Director/Board Member 64 2017-03-21
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.37%+7.25%+63.28%+51.33% 10.98B
+0.30%+1.58%-15.62%+139.96% 710B
-0.50%+0.57%+5.00%-11.99% 379B
-1.31%+1.67%+14.46%+25.91% 344B
-3.64%+0.24%-55.03%+9.87% 317B
-2.36%-0.31%+3.13%-20.22% 265B
-3.00%-0.59%-2.11%+16.28% 244B
-1.66%+2.41%-13.48%-5.38% 223B
-0.79%+3.00%-34.52%-10.15% 211B
-1.70%-1.00%-8.21%+18.83% 162B
Average -1.31%+2.01%-4.31%+21.44% 286.56B
Weighted average by Cap. -1.23%+1.13%-11.25%+36.90%
See all sector performances

Financials

2025 *2026 *
Net sales 1.68B 1.96B 1.56B 1.45B 2.68B 168B 2.98B 18.76B 7.14B 78.8B 7.36B 7.2B 289B 1.97B 2.31B 1.84B 1.71B 3.16B 198B 3.51B 22.08B 8.41B 92.74B 8.66B 8.48B 340B
Net income 366M 428M 341M 318M 586M 36.76B 651M 4.1B 1.56B 17.21B 1.61B 1.57B 63.15B 534M 624M 497M 463M 854M 53.54B 948M 5.97B 2.27B 25.07B 2.34B 2.29B 92B
Net Debt 44.11M 51.55M 41.06M 38.22M 70.57M 4.42B 78.34M 493M 188M 2.07B 193M 189M 7.6B -145M -169M -135M -125M -232M -14.51B -257M -1.62B -616M -6.8B -634M -621M -24.94B
More financial data * Estimated data
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - generic, OTC and biosimilar drugs (43.4%); - patented prescription products (41.7%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - animal health products (8.7%); - pharmaceutical ingredients and outsourcing services (6.2%). Net sales break down primarily by source of revenue between sales of products (86.9%) and royalties (10.4%). Net sales are distributed geographically as follows: Finland (28%), Scandinavia (12%), Europe (30.8%), North America (14.7%) and other (14.5%).
Employees
3,943
More about the company
Date Price Change Volume
25-07-11 66.60 -0.37% 133,967
25-07-10 66.85 +1.83% 221,243
25-07-09 65.65 0.00% 393,891
25-07-08 65.65 +3.55% 307,083
25-07-07 63.40 +0.48% 149,917

Delayed Quote Nasdaq Helsinki, July 11, 2025 at 12:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
66.60EUR
Average target price
58.50EUR
Spread / Average Target
-12.16%
Consensus

Quarterly revenue - Rate of surprise